PLAG1 dampens protein synthesis to promote human hematopoietic stem cell self-renewal

Ava Keyvani Chahi,Muluken S. Belew,Joshua Xu,He Tian Tony Chen,Stefan Rentas,Veronique Voisin,Gabriela Krivdova,Eric Lechman,Sajid A. Marhon,Daniel D. De Carvalho,John E. Dick,Gary D. Bader,Kristin J. Hope,Ava Keyvani Chahi,Joshua Xu,He Tian Tony Chen,Stefan Rentas,Veronique Voisin,Gabriela Krivdova,John E. Dick
DOI: https://doi.org/10.1182/blood.2021014698
IF: 20.3
2022-09-01
Blood
Abstract:Hematopoietic stem cell (HSC) dormancy is understood as supportive of HSC function and its long-term integrity. Although regulation of stress responses incurred as a result of HSC activation is recognized as important in maintaining stem cell function, little is understood of the preventive machinery present in human HSCs that may serve to resist their activation and promote HSC self-renewal. We demonstrate that the transcription factor PLAG1 is essential for long-term HSC function and, when overexpressed, endows a 15.6-fold enhancement in the frequency of functional HSCs in stimulatory conditions. Genome-wide measures of chromatin occupancy and PLAG1-directed gene expression changes combined with functional measures reveal that PLAG1 dampens protein synthesis, restrains cell growth and division, and enhances survival, with the primitive cell advantages it imparts being attenuated by addition of the potent translation activator, c-MYC. We find PLAG1 capitalizes on multiple regulatory factors to ensure protective diminished protein synthesis including 4EBP1 and translation-targeting miR-127 and does so independently of stress response signaling. Overall, our study identifies PLAG1 as an enforcer of human HSC dormancy and self-renewal through its highly context-specific regulation of protein biosynthesis and classifies PLAG1 among a rare set of bona fide regulators of messenger RNA translation in these cells. Our findings showcase the importance of regulated translation control underlying human HSC physiology, its dysregulation under activating demands, and the potential if its targeting for therapeutic benefit.
hematology
What problem does this paper attempt to address?